Table 3—

Overall AE with a rate of occurrence in two or more patients

Placebo groupGLP-1 4 ng · kg–1 · min–1 16-h groupGLP-1 8 ng · kg–1 · min–1 16-h groupGLP-1 4 ng · kg–1 · min–1 24-h groupGLP-1 8 ng · kg–1 · min–1 24-h group
Patients with at least one event65747
Total number of unique events141421729
Cellulitis20012
Fever11002
Chills01001
Headache32223
Injection site reaction20002
Abdominal pain22201
Back pain00103
Diarrhea00101
Dyspepsia00322
Nausea12404
Vomiting12313
Dizziness01301
Tremor01001
  • Data are n.